small cell lung cancer

with clinical response to gefitinib therapy. Science 2004; 304: 1497–1500. 3. Inoue A, Suzuki T, Fukuhara T et al. Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations. J Clin Oncol 2006; 24: 3340–3346. 4. Asahina H, Yamazaki K, Kinoshita I et al. A phase II trial of gefitinib as fir...

متن کامل

Genetic variant of miR-4293 rs12220909 is associated with susceptibility to non-small cell lung cancer in a Chinese Han population

2017

Lixia Fan Linqi Chen Xiaoling Ni Shicheng Guo Yinghui Zhou Chenji Wang Yabiao Zheng Fangyuan Shen Vijay Kumar Kolluri Merlin Muktiali Zhenhong Zhao Junjie Wu Dunmei Zhao Zhenglei He Xulong Feng Ziyu Yuan Juan Zhang Li Jin Jiucun Wang Minghua Wang

Non-small cell lung cancer is one of the most common cancers and the leading cause of cancer death worldwide. Genetic variants in regulatory regions of some miRNAs might be involved in non-small cell lung cancer susceptibility and survival. rs12220909 (G/C) genetic polymorphism in miR-4293 has been shown to be associated with decreased risk of esophageal squamous cell carcinoma. However, the in...

متن کامل

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید